Insights On Regulatory Compliance
-
Richter BioLogics Drives Efficiency And Compliance With Unified Quality
1/21/2026
Learn how one CDMO tripled production, improved audit readiness, and built customer trust by unifying quality systems and embracing a digital-first approach.
-
Little Patients, Big Challenges: Developing Pediatric Formulations
5/12/2025
Explore the development of high-quality, child-friendly oral formulations, as well as learn about new testing requirements for impurities and innovative approaches to creating age-appropriate medications.
-
Pharmaceutical Bioburden And Microbial Limits Testing
3/5/2026
Explore how membrane filtration tools streamline bioburden and microbial enumeration while improving ergonomics and easing routine tasks in fast‑paced pharmaceutical microbiology labs.
-
Scientific Data Is Not AI‑Ready By Default
6/26/2026
Convert siloed laboratory data into trusted, AI-ready assets. Learn to enforce data integrity principles at the point of origin to streamline analytics and reduce GxP compliance risks.
-
The Patent Cliff Looms – Design Your Biosimilar Approach Accordingly
3/3/2025
In your pursuit of developing a high-quality biosimilar, think strategically. Consider what type of biologic your team’s expertise can support and which is needed most in your target market.
-
Contamination Control Of Particulate And Shuttle Blow-Fill-Seal Compliance
2/24/2026
Does shuttle blow-fill-seal truly meet Annex 1’s stricter contamination standards? New particle burden data challenges industry assumptions and reveals what manufacturers need to know.
-
Turn Regulatory Readiness Into An Operational Advantage
5/22/2026
Paper-based GxP workflows hide risk and stall progress. Learn how embedding compliance into digital execution creates real-time traceability and turns regulatory readiness into an advantage.
-
Revolutionizing Aseptic Fill/Finish With Innovation
4/21/2025
Experience an innovative aseptic fill-finish technology designed for ATMP production in this live demo, which is a cutting-edge solution that ensures optimal efficiency and product quality.
-
FDA's CSA Guidance Is Final: What It Means For Your Validation Strategy
3/23/2026
Understand the FDA's shift from rigid CSV to risk-based software assurance. Binary risk classification and flexible testing approaches reduce validation timelines for production and quality.
-
How Do You Navigate GxP Compliance?
4/21/2026
Heightened FDA scrutiny demands a shift from fragmented data to unified digital systems. Learn how to automate QA tasks, secure data integrity, and maintain a constant state of inspection readiness.